A Novel Alkylating Agent, Glufosfamide, Enhances the Activity of Gemcitabine In vitro and In vivo

Lignende værker

• The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
  af: Akashi, Y, et al.
  Udgivet: (2007)
• In vitro and In vivo Antitumor Activity of a Novel Alkylating Agent Melphalan-flufenamide Against Multiple Myeloma Cells
  af: Chauhan, Dharminder, et al.
  Udgivet: (2013)
• Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo
  af: Saito, Nobuhiro, et al.
  Udgivet: (2018)
• Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents
  af: Leiba, Merav, et al.
  Udgivet: (2012)
• In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma
  af: Xue, Cong, et al.
  Udgivet: (2016)